Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Goal Directed Fluid Removal With Furosemide in Intensive Care Patients With Fluid Overload - A Randomised, Blinded, Placebo-controlled Trial (GODIF).

NCT04180397 is registered in ClinicalTrials.gov with Morten H. Bestle as lead sponsor.

NCT NCT04180397
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04180397 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Goal Directed Fluid Removal With Furosemide in Intensive Care Patients With Fluid Overload - A Randomised, Blinded, Placebo-controlled Trial (GODIF).
Lead sponsor
Morten H. Bestle
Phase
Phase 4
Overall status
Recruiting
Start date
August 17, 2020
Completion date
April 15, 2028
Enrollment
1,000 (estimated)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

fluid overload